High hopes dashed: HIV vaccine made from GSK, Sanofi components flops massive study

Researchers had high hopes for an HIV vaccine candidate made up of components supplied by GlaxoSmithKline and Sanofi. But several years into the study, researchers took a peek at the data in January. It wasn’t working.
Source: FiercePharma | For Pharmaceuticals Industry Pros RSS Feed

Leave a Reply

Your email address will not be published. Required fields are marked *